Results 111 to 120 of about 427,983 (270)

Opsonin-Independent Phagocytosis of Activators of the Alternative Complement Pathway by Human Monocytes [PDF]

, 1978
J K Czop, Douglas T. Fearon, K. Frank Austen   +2 more
openalex   +1 more source

Long non‐coding RNAs as therapeutic targets in head and neck squamous cell carcinoma and clinical application

FEBS Open Bio, EarlyView.
Long non‐coding RNAs (lncRNAs) occupy an abundant fraction of the eukaryotic transcriptome and an emerging area in cancer research. Regulation by lncRNAs is based on their subcellular localization in HNSCC. This cartoon shows the various functions of lncRNAs in HNSCC discussed in this review.
Ellen T. Tran, Ruchi A. Patel, Amogh Chariyamane, Ratna B. Ray   +3 more
wiley   +1 more source

Inactivation or elimination of potentially trypanolytic, complement-activating immune complexes by pathogenic trypanosomes [PDF]

, 1979
Andrew E. Balber, James D. Bangs, Sheelagh M.A. Jones, Richard L. Proia   +3 more
openalex   +1 more source

Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets. [PDF]

, 1977
Richard H. Dixon, Wendell F. Rosse
openalex   +1 more source

In vivo transit dosimetry methodology for whole breast intensity modulated radiation therapy

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Background In vivo transit dosimetry using an electronic portal imaging device (EPID‐IVTD) is an important tool for verifying the accuracy of radiation therapy treatments. Despite its potential, the implementation of EPID‐IVTD in breast intensity modulated radiation therapy (IMRT) treatments has not yet been standardized, limiting its clinical
Lucia Zirone, Elisa Bonanno, Giuseppina R. Borzì, Nina Cavalli, Alessia D'Anna, Andrea Girlando, Martina Pace, Giuseppe Stella, Carmelo Marino   +8 more
wiley   +1 more source

Sample processing time but not storage time affects complement activation markers C4a, C4d, C3a, iC3b, Bb, C5a, and sC5b-9 levels in EDTA-plasma of individuals at clinical high-risk for psychosis

Biomarkers in Neuropsychiatry
The complement system is an important part of the innate immune system and plays a key role in inflammatory processes. Concentrations of complement activation fragments in plasma are markers of systemic activation and have been found to be altered in a ...
Eleftheria Kodosaki, Colm Healy, Jonah F. Byrne, Melanie Föcking, Mary Cannon, Diana O. Perkins, David Cotter, Meike Heurich   +7 more
doaj  

Weight Sparsity Complements Activity Sparsity in Neuromorphic Language Models [PDF]

arXiv
Activity and parameter sparsity are two standard methods of making neural networks computationally more efficient. Event-based architectures such as spiking neural networks (SNNs) naturally exhibit activity sparsity, and many methods exist to sparsify their connectivity by pruning weights.
arxiv  

Position‐dependent offset corrections for ring applicator reconstruction in cervical cancer brachytherapy

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose Due to the tight curvature in their design, ring applicators are usually associated with large positioning errors. The standard practice to correct for these deviations based on global offsets may not be sufficient to comply with the recommended tolerance.
Leon G. Aldrovandi, Matthias E. T. Dessein, Shelley M. Pearson, Shelley M. Bulling   +3 more
wiley   +1 more source

Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans [PDF]

, 1979
K A Laxalt, Thomas R. Kozel
openalex   +1 more source

An extension to the OVH concept for knowledge‐based dose volume histogram prediction in lung tumor volumetric‐modulated arc therapy

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose Volumetric‐modulated arc therapy (VMAT) treatment planning allows a compromise between a sufficient coverage of the planning target volume (PTV) and a simultaneous sparing of organs‐at‐risk (OARs). Particularly in the case of lung tumors, deciding whether it is possible or worth spending more time on further improvements of a treatment
Johann Brand, Juliane Szkitsak, Oliver J. Ott, Christoph Bert, Stefan Speer   +4 more
wiley   +1 more source